Table 3.
Reasons for ending prophylaxis with micafungin in 101 of the 104 total episodes.
| End of prophylaxis | 65 (64.4%) |
| Adverse reaction | 0 (0%) |
| Empirical treatment | 19 (18.8) |
| Change of antifungal | 7 (6.9%) |
| Other | 10 (9.9%) |
| Total | 101 evaluable episodes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.